4-吗啉甲基苯硼酸 | 279262-23-6

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-吗啉甲基苯硼酸
• 中文别名: 4-(吗啉甲基)苯硼酸；B-[4-(4-吗啉甲基)苯基]硼酸
• 英文名称: (4-(morpholinomethyl)phenyl)boronic acid
• 英文别名: 4-(morpholin-4-ylmethyl)phenylboronic acid；4-(Morpholinomethyl)phenylboronic acid；[4-(morpholin-4-ylmethyl)phenyl]boronic acid
• CAS: 279262-23-6
• 化学式: C₁₁H₁₆BNO₃
• mdl: MFCD16661158
• 分子量: 221.064
• InChiKey: QPFDUULIDNELSE-UHFFFAOYSA-N

物化性质

• 熔点：
  85 °C
• 沸点：
  382.3±52.0 °C(Predicted)
• 密度：
  1.20

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  52.9
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2934999090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(4-Morpholinylmethyl)phenylboronic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(4-Morpholinylmethyl)phenylboronic acid
CAS number: 279262-23-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H16BNO3
Molecular weight: 221.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-吗啉甲基苯硼酸 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 potassium tert-butylate 、 sodium carbonate 、 三(邻甲基苯基)磷 作用下， 以 1,4-二氧六环 、 水 、 二甲基亚砜 为溶剂， 反应 24.0h， 生成 4-(3-methyl-5-(4-(morpholinomethyl)phenyl)pyridin-2-yl)-2-((6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)morpholine
  参考文献：
  名称：

  新的抗癌化合物及其用途

  摘要：

  本发明提供新的抗癌化合物为化学式1化合物或其药学上可允许的盐，它们是肝细胞生长因子受体（c‑Met）酪氨酸激酶活性抑制用药剂学组合物及过度或异常增殖性疾病的预防或治疗用药剂学组合物的有效成分。本发明所述化合物有效地抑制肝细胞生长因子受体酪氨酸激酶的活性，从而能够适用于治疗特征为过度或异常细胞增殖性疾病。

  公开号：

  CN109796456A
• 作为产物：
  描述：

  在 水 、 silica gel 作用下， 以 乙酸乙酯 为溶剂， 反应 3.0h， 以87%的产率得到4-吗啉甲基苯硼酸
  参考文献：
  名称：

  通过硅胶和水有效水解有机三氟硼酸盐

  摘要：

  开发了一种使用硅胶和 H 2 O水解有机三氟硼酸盐以揭示硼酸的通用、温和且有效的方法。事实证明，该方法可以耐受各种芳基-、杂芳基-、烯基-和烷基三氟硼酸盐以及结构多样的氨甲基化有机三氟硼酸盐。正如预期的那样，由于共振稳定的二氟硼烷中间体，富电子底物比缺电子底物更容易提供相应的硼酸。开发的方法进一步扩展用于将有机三氟硼酸盐转化为相应的硼酸酯。

  DOI：

  10.1021/jo901441u

文献信息

• 3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1
  作者：Fangrui Wu、Chao Zhou、Yuan Yao、Liping Wei、Zizhen Feng、Lisheng Deng、Yongcheng Song

  DOI：10.1021/acs.jmedchem.5b01361

  日期：2016.1.14

  overexpression. We report the design, synthesis, and structure–activity relationships of 3-(piperidin-4-ylmethoxy)pyridine containing compounds as potent LSD1 inhibitors with Ki values as low as 29 nM. These compounds exhibited high selectivity (>160×) against related monoamine oxidase A and B. Enzyme kinetics and docking studies suggested they are competitive inhibitors against a dimethylated H3K4 substrate

  组蛋白赖氨酸残基的甲基化在基因表达调节以及癌症起始中起重要作用。赖氨酸特异性脱甲基酶1（LSD1）负责维持组蛋白H3赖氨酸4（H3K4）的平衡甲基化水平。由于甲基化的H3K4或LSD1过表达的重要功能，LSD1是某些癌症的药物靶标。我们报告了作为有效LSD1抑制剂的含有3-（哌啶-4-基甲氧基）吡啶的化合物（与K i的设计，合成和结构-活性关系）值低至29 nM。这些化合物对相关的单胺氧化酶A和B表现出高选择性（> 160x）。酶动力学和对接研究表明它们是针对二甲基化H3K4底物的竞争性抑制剂，并提供了可能的结合方式。有效的LSD1抑制剂可以增加细胞H3K4甲基化并强烈抑制EC 50值低至280 nM的几种白血病和实体瘤细胞的增殖，而对正常细胞的作用却微不足道。
• [EN] TRICYCLIC DEGRADERS OF IKAROS AND AIOLOS<br/>[FR] AGENTS DE DÉGRADATION TRICYCLIQUES D'IKAROS ET D'AIOLOS
  申请人：C4 THERAPEUTICS INC

  公开号：WO2020210630A1

  公开（公告）日：2020-10-15

  Tricyclic cereblon binders for the degradation of Ikaros or Aiolos by the ubiquitin proteasome pathway for therapeutic applications are described.

  三环脑蛋白结合剂通过泛素蛋白酶体途径降解Ikaros或Aiolos以用于治疗应用的描述。
• Optimized HSP90 mediated fluorescent probes for cancer-specific bioimaging
  作者：Shulei Zhu、Yalei Li、Yushu Huang、Minmin Zhang、Xiaofan Gu、Yang He、Hongchun Liu、Mingliang Ma、Wei Lu

  DOI：10.1039/c9tb02505g

  日期：——

  NP-001is a promising imaging probe for detection and visualization of tumor lesions, offering low side effect and good biocompatibility.

  NP-001是一种有前景的成像探针，用于检测和可视化肿瘤病灶，具有低副作用和良好的生物相容性。
• [EN] SUBSTITUTED BENZAZINONES AS ANTIBACTERIAL COMPOUNDS<br/>[FR] BENZAZINONES SUBSTITUÉS À UTILISER EN TANT QUE COMPOSÉS ANTIBACTÉRIENS
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2017098440A1

  公开（公告）日：2017-06-15

  The present invention relates to LpxC antibacterial compounds of Formula (1A), corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions:, compound preparation, treatment methods and uses for bacterial infections, especially those caused by gram-negative bacteria.

  该发明涉及Formula (1A)的LpxC抗菌化合物，其相应的药学上可接受的盐，相应的药物组合物，化合物制备，细菌感染的治疗方法和用途，特别是由革兰氏阴性细菌引起的感染。
• Aryl- or Heteroaryl-Substituted Benzene Compounds
  申请人：KUNTZ KEVIN W.

  公开号：US20120264734A1

  公开（公告）日：2012-10-18

  The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

  本发明涉及芳基或杂芳基取代的苯化合物。本发明还涉及含有这些化合物的药物组合物，以及通过向需要的受试者投与这些化合物和药物组合物来治疗癌症的方法。本发明还涉及利用这些化合物进行研究或其他非治疗目的的用途。